X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons

Journal of Neurochemistry

Volumn 124, Issue 2, 2013, Pages 250-261

  Dučić, Tanja ^a   Barski, Elisabeth ^b   Salome, Murielle ^c   Koch, Jan C ^b   Bähr, Mathias ^b,d   Lingor, Paul ^b,d  

^a DESY   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

^d Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain   (Germany)

Author keywords

iron; manganese; oxidative state; Parkinson's disease; primary dopaminergic neurons; X ray fluorescence microscopy

Indexed keywords

FERROUS ION; IRON; MANGANESE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYOPRESERVATION; DOPAMINERGIC NERVE CELL; EMBEDDING; FLUORESCENCE MICROSCOPY; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NEUROANATOMICAL TRACT TRACING; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE STUDY; SIGNAL DETECTION; X RAY ABSORPTION SPECTROSCOPY; X RAY FLUORESCENCE;

ANIMALS; DOPAMINERGIC NEURONS; GREEN FLUORESCENT PROTEINS; IRON; MANGANESE; MICE; MICE, TRANSGENIC; PARKINSON DISEASE; PRIMARY CELL CULTURE; SPECTROMETRY, X-RAY EMISSION;

EID: 84871607264     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12073     Document Type: Article

References (41)

1. Bacquart T., et al,. (2007) Subcellular Speciation Analysis of Trace Element Oxidation States Using Synchrotron Radiation Micro-X-ray Absorption Near-Edge Structure. Anal. Chem. 79, 7353-7359.
2. Benedetto A., et al,. (2010) Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet. 6, e1001084. doi: 10.1371/journal.pgen.1001084.
3. Berg D., and, Hochstrasser H., (2006) Iron metabolism in Parkinsonian syndromes. Mov. Disord. 21, 1299-1310.
4. Braak, H., Del Tredici, K., Rüb, U., de Vos, R. A., Jansen Steur, E. N., and, Braak, E., (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211.
5. Carmona A., Devès G., and, Ortega R., (2008) Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques. Anal. Bioanal. Chem. 390, 1585-1594.
6. Chew K. C. M., et al,. (2011) Enhanced autophagy from chronic toxicity of iron and mutant A53T α-synuclein: implications for neuronal cell death in Parkinson disease. J. Biol. Chem. 286, 33380-33389.
7. Cotte M., et al,. (2007) Synchrotron-based X-ray spectromicroscopy used for the study of an atypical micrometric pigment in 16th century paintings. Anal. Chem. 79, 6988-6994.
8. Covy J. P., and, Giasson B. I., (2010) The G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition. J. Neurochem. 115, 36-46.
9. Crossgrove J. S., and, Yokel R. A., (2004) Manganese distribution across the blood-brain barrier III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 25, 451-460.
10. Crossgrove J. S., and, Yokel R. A., (2005) Manganese distribution across the blood-brain barrier. IV. Evidence for brain influx through store-operated calcium channels. Neurotoxicology 26, 297-307.
11. Ducić T., et al,. (2011) Structure and composition of myelinated axons: a multimodal synchrotron spectro-microscopy study. J. Struct. Biol. 173, 202-212.
12. Erikson K. M., et al,. (2002) Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol. Trace Elem. Res. 87, 143-156.
13. Eriksson H., et al,. (1987) Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch. Toxicol. 61, 46-52.
14. Fasano M., Bergamasco B., and, Lopiano L., (2006) Modifications of the iron-neuromelanin system in Parkinson's disease. J. Neurochem. 96, 909-916.
15. Gaasch J. A., et al,. (2007) Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem. Res. 32, 1686-1693.
16. Guilarte T. R., (2010) Manganese and Parkinson's disease: a critical review and new findings. Environ. Health Perspect. 118, 1071-1080.
17. HaMai D., Campbell A., and, Bondy S. C., (2001) Modulation of oxidative events by multivalent manganese complexes in brain tissue. Free Radical Biol. Med. 31, 763-768.
18. Harrison P. M., and, Arosio P., (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161-203.
19. Ide-Ektessabi A., and, Rabionet M., (2005) The role of trace metallic elements in neurodegenerative disorders: quantitative analysis using XRF and XANES spectroscopy. Anal. Sci. 21, 885-892.
20. Jomova K., et al,. (2010) Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 345, 91-104.
21. Kalia K., Jiang W., and, Zheng W., (2008) Manganese accumulates primarily in nuclei of cultured brain cells. Neurotoxicology 29, 466-470.
22. Kostka M., et al,. (2008) Single Particle Characterization of Iron-induced Pore-forming -Synuclein Oligomers. J. Biol. Chem. 283, 10992-11003.
23. Lingor P., Unsicker K., and, Krieglstein K., (2000) GDNF and NT-4 Protect Midbrain Dopaminergic Neurons from Toxic Damage by Iron and Nitric Oxide. Exp. Neurol. 163, 55-62.
24. Matsushita N., et al,. (2002) Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development. J. Neurochem. 82, 295-304.
25. Mertz L. M., Baum B. J., and, Ambudkar I. S., (1992) Membrane potential modulates divalent cation entry in rat parotid acini. J. Membr. Biol. 126, 183-193.
26. Migheli R., et al,. (1999) Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress. J. Neurochem. 73, 1155-1163.
27. Moos T., et al,. (2007) Iron trafficking inside the brain. J. Neurochem. 103, 1730-1740.
28. Olanow C. W., et al,. (1996) Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 46, 492-498.
29. Ortega R., et al,. (2007) Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging. PLoS ONE, 2, e925.
30. Ortega R., Devès G., and, Carmona A., (2009) Bio-metals imaging and speciation in cells using proton and synchrotron radiation X-ray microspectroscopy. J. R. Soc. Interface 6 (Suppl 5), S649-S658.
31. Papanikolaou G., and, Pantopoulos K., (2005) Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202, 199-211.
32. Paunesku T., et al,. (2006) X-ray fluorescence microprobe imaging in biology and medicine. J. Cell. Biochem. 99, 1489-1502.
33. Qin Z., et al,. (2011) Trace metal imaging with high spatial resolution: applications in biomedicine. Metallomics 3, 28.
34. Salazar J., et al,. (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 18578-18583.
35. Shimoda K., et al,. (1992) A high percentage yield of tyrosine hydroxylase-positive cells from rat E14 mesencephalic cell culture. Brain Res. 586, 319-331.
36. Sikk K., et al,. (2011) Manganese-Induced Parkinsonism due to Ephedrone Abuse. Parkinson's Dis. 2011, doi: 10.4061/2011/865319.
37. Strickland D., and, Bertoni J. M., (2004) Parkinson's prevalence estimated by a state registry. Mov. Disord. 19, 318-323.
38. Szczerbowska-Boruchowska M., et al,. (2007) Biomolecular investigation of human substantia nigra in Parkinson's disease by synchrotron radiation Fourier transform infrared microspectroscopy. Arch. Biochem. Biophys. 459, 241-248.
39. Uversky V. N., Li J., and, Fink A. L., (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276, 44284-44296.
40. Yokel R. A., (2009) Manganese flux across the blood-brain barrier. NeuroMol. Med. 11, 297-310.
41. Zecca L., et al,. (2003) Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci. 26, 578-580.